1. Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT). (4th March 2018) Authors: Glimelius, Bengt; Manojlovic, Nebojsa; Pfeiffer, Per; Mosidze, Baadur; Kurteva, Galina; Karlberg, Mia; Mahalingam, Devalingam; Buhl Jensen, Peter; Kowalski, Jan; Bengtson, Marie; Nittve, Malin; Näsström, Jacques Journal: Acta oncologica Issue: Volume 57:Number 3(2018) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. Issue 8 (9th August 2018) Authors: Van Cutsem, Eric; Hidalgo, Manuel; Canon, Jean‐Luc; Macarulla, Teresa; Bazin, Igor; Poddubskaya, Elena; Manojlovic, Nebojsa; Radenkovic, Dejan; Verslype, Chris; Raymond, Eric; Cubillo, Antonio; Schueler, Armin; Zhao, Charles; Hammel, Pascal Journal: International journal of cancer Issue: Volume 143:Issue 8(2018) Page Start: 2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗